0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Case Report/Case Series |

Hypokalemic Periodic Paralysis Induced by Thymic Hyperplasia and Relieved by Thymectomy

Renrong Yang, MD1; Karin Jurkat-Rott, MD2; Jinlin Cao, MD1; Guofeng Wang, MD3; Hans-Peter Seelig, MD4; Changping Yang, MD1; Guibao Liu, MD1; Lin Pan, MD5; Haiyan Zheng, MD1; Frank Lehmann-Horn, MD2
[+] Author Affiliations
1Department of Thoracic Surgery, 117 PLA Hospital, Hangzhou, China
2Division of Neurophysiology, Neuromuscular Disease Center, and Rare Disease Center, Ulm University, Ulm, Germany
3Department of Pathology, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
4Medizinisches Versorgungszentrum, Karlsruhe, Germany
5Department of Neurology, 117 PLA Hospital, Hangzhou, China
JAMA Neurol. 2013;70(11):1436-1439. doi:10.1001/jamaneurol.2013.3918.
Text Size: A A A
Published online

Importance  Hypokalemic periodic paralysis is a muscle channelopathy based on mutations or predisposing variants or secondary to potassium wasting. In contrast to myasthenia gravis, an association with thymic hyperplasia has not yet been reported, to our knowledge.

Observations  We report a male patient in his mid-20s with progressive episodes of flaccid muscle weakness, associated low serum potassium levels, and a pathologic decrement in the long exercise test. Because the familial inheritance in the family was initially unknown, thorough diagnostic tests were performed including contrast-enhanced computed tomography scan, which displayed a mass in the anterior mediastinum. The test results for autoantibodies against myasthenia gravis (acetylcholine receptor, muscle-specific tyrosine kinase, and low-density lipoprotein receptor–related protein 4) and other end plate channelopathies were negative, and test results for hypokalemia-inducing hormones (thyroid, corticotropin, and cortisol) were negative. Surgery identified a thymus of 13 × 8 × 3 cm3. Histologic analysis was consistent with thymic hyperplasia of the follicular subtype and immunohistologic analysis showed cytokeratin 5/6 in hyperplastic epithelial cells. A 2-year follow-up revealed the postoperative absence of weakness episodes. As in 30% of familial cases, molecular genetics testing failed to identify a mutation in periodic paralysis genes.

Conclusions and Relevance  Thymic hyperplasia can clinically manifest susceptibility to hypokalemic periodic paralysis. For patients with late onset or increasing weakness episodes, we recommend imaging to assess for thymic enlargement and thymectomy at thymic hyperplasia.

Figures in this Article

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Place holder to copy figure label and caption
Figure 1.
Long Exercise Tests

The compound muscle action potentials of the patient and his affected uncle show a typical late decrement in contrast to the healthy control. For details, see the Methods subsection.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.
Images of the Enlarged Thymus

A, Mass without involvement of the surrounding tissue on the contrast-enhanced computed tomography scan of the anterior mediastinum. B, Hyperplastic thymus with lobular appearance and fibrous capsule. C, Lobular architecture, cortex, medulla, and Hassall corpuscles and adipose tissue in the stroma (hematoxylin-eosin, original magnification ×100). D, Immunostaining of cytokeratin 5/6 in hyperplastic epithelial cells (original magnification ×200).

Graphic Jump Location

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
Jobs
brightcove.createExperiences();